CID 1091543

4-morpholineacetamide, n-(5-methyl-1,3,4-thiadiazol-2-yl)-

Structural Information

Molecular Formula
C9H14N4O2S
SMILES
CC1=NN=C(S1)NC(=O)CN2CCOCC2
InChI
InChI=1S/C9H14N4O2S/c1-7-11-12-9(16-7)10-8(14)6-13-2-4-15-5-3-13/h2-6H2,1H3,(H,10,12,14)
InChIKey
VVFXNWLPOPZNHQ-UHFFFAOYSA-N
Compound name
N-(5-methyl-1,3,4-thiadiazol-2-yl)-2-morpholin-4-ylacetamide
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

11
Patents

242.08374 Da
Monoisotopic Mass

0.0
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 243.091016 152.5
[M+Na]+ 265.072958 158.9
[M-H]- 241.076464 155.7
[M+NH4]+ 260.117563 166.5
[M+K]+ 281.046898 157.6
[M+H-H2O]+ 225.081000 144.1
[M+HCOO]- 287.081941 166.0
[M+CH3COO]- 301.097591 189.4
[M+Na-2H]- 263.058406 153.8
[M]+ 242.08319142 151.9
[M]- 242.08428858 151.9
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

patents stripe